Court Ruling Blocks Potential Apple Watch Import Ban in Patent Dispute

Federal appeals court upholds invalidation of AliveCor's patents, dismissing ITC's import ban recommendation.

The U.S. Court of Appeals upheld a decision invalidating three AliveCor patents related to EKG technology used in the Apple Watch.
This ruling effectively nullifies the International Trade Commission's earlier recommendation for an Apple Watch import ban.
AliveCor originally accused Apple of infringing on its patents in 2021, but the patents were later deemed unpatentable by the Patent Trial and Appeal Board (PTAB).
AliveCor expressed disappointment with the decision and stated its intention to explore further legal options to defend its intellectual property claims.
Apple welcomed the ruling, emphasizing its commitment to developing innovative health and wellness features for its products.